Lv512
1210 积分 2022-04-14 加入
International Eczema Council Definitions of Low Disease Activity and Remission in Atopic Dermatitis: A Consensus Statement
2小时前
已完结
Drugs and Bugs in Atopic Dermatitis: Benefits to the Skin Microbiome from Targeted Immunotherapies
3小时前
求助中
Rezpegaldesleukin treatment of moderate-to-severe atopic dermatitis (REZOLVE-AD): final results from the 16-week induction period of an international, double-blind, placebo-controlled, randomised phase 2b study
4小时前
已完结
Effect of Abrocitinib on the Skin Microbiome in Patients With Moderate-to-Severe Atopic Dermatitis
1天前
已完结
Withdrawal of immunosuppressants and low-dose steroids in patients with stable IgG4-RD (WInS IgG4-RD): an investigator-initiated, multicentre, open-label, randomised controlled trial
1天前
已完结
Cutaneous Hypersensitivity Reactions to Immune Checkpoint Inhibitors
2天前
已完结
Comparative effectiveness and safety of upadacitinib, abrocitinib and dupilumab in treatment-resistant prurigo nodularis
2天前
已完结
Development of a clinical algorithm to predict phenotypic switches between atopic dermatitis and psoriasis (the "Flip-Flop" phenomenon)
3天前
已完结
Autoimmune haemolytic anaemias
5天前
已完结
Efficacy and safety of rituximab induction therapy and effect of rituximab maintenance for IgG4-related disease: a systematic review and meta-analysis
7天前
已完结
皖公网安备34019202002308
